Synthesis, Docking Studies into CDK-2 and Anticancer Activity of New Derivatives Based Pyrimidine Scaffold and Their Derived Glycosides-Reference-Cited by-同舟云学术

Synthesis, Docking Studies into CDK-2 and Anticancer Activity of New Derivatives Based Pyrimidine Scaffold and Their Derived Glycosides

Published:2019-08-21 Issue:13 Volume:19 Page:1093-1110
ISSN:1389-5575
Container-title:Mini-Reviews in Medicinal Chemistry
language:en
Short-container-title:MRMC

Author:

Rahman Adel A.H. Abdel¹,Nassar Ibrahim F.²,Shaban Amira K.F.¹,EL-Kady Dina S.³,Awad Hanem M.⁴,El Sayed Wael A.⁵

Affiliation:

1. Chemistry Department, Faculty of Science, Menofia University, Shebin El-Kom, Egypt

2. Faculty of Specific Education, Ain Shams University, Abassia, Cairo, Egypt

3. Hormone Department, National Research Centre, Dokki, Cairo, Egypt

4. Tanning Materials and Leather Technology Department, National Research Centre, Dokki, Cairo, Egypt

5. Chemistry Department, Faculty of Science, Qassim University, Buraydah, Saudi Arabia

Abstract

Background & Objective:New diaryl-substituted pyrimidinedione compounds, their thioxo derivatives as well as their bicyclic thiazole compounds were synthesized and characterized.Methods:The glycosylamino derivatives of the synthesized disubstituted derivatives of the pyrimidine scaffold were also prepared via reaction of the N3-amino derivatives with a number of monosaccharides followed by acetylation.Results:The anticancer activity of the synthesized compounds was studied against human liver cancer (HepG2) and RPE-1cell lines. Compounds 2a, 2b, 3a and 12 showed potent activities with IC50 results comparable to that of doxorubicin.Conclusion:Docking investigations into Cyclin-dependent kinase 2 (CDK-2) enzyme, a potential target for cancer medication, were also reported showing the possible binding interaction into the enzyme active site to support their activity behavior.

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology,General Medicine

Reference54 articles.

1. Morgan D.O.; The cell cycle: Principles of control New Science Press: London.2007

2. Lee M.G.; Nurse P.; Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2. Nature 1987,327,31-35

3. Peyressatre M.; Prével C.; Pellerano M.; Morris M.C.; Targeting cyclin-dependent kinases in human cancers: From small molecules to peptide inhibitors. Cancers 2015,7,179-237

4. Rossi A.G.; Sawatzky D.A.; Walker A.; Ward C.; Sheldrake T.A.; Riley N.A.; Caldicott A.; Martinez-Losa M.; Walker T.R.; Duffin R.; Gray M.; Crescenzi E.; Martin M.C.; Brady H.J.; Savill J.S.; Dransfield I.; Haslett C.; Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat Med 2006,12,1056-1064

5. Senderowicz A.M.; Flavopiridol the first cyclin-dependent kinase inhibitor in human clinical trials. Invest New Drugs 1999,17,313-320

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of Some 1,2,3-triazole-bridged glycosides with benzoquniline-3-carbonitriles via click chemistry for anticancer, and docking evaluation;Journal of Molecular Structure;2025-02

2. Design, synthesis and molecular modeling of pyrazoline based coumarin derivatives as tubulin polymerization inhibitors;Journal of Molecular Structure;2024-12

3. Pyridine-based glycosides bearing 1,2,4-triazole and their 1,3,4-oxadiazole analogues as potential EGFR and CDK-2 inhibitors: Design, synthesis, antiproliferative activity and in silico studies;Journal of Molecular Structure;2024-10

4. Synthesis, anticancer activity, docking and computational studies of new pyridyl-glycosyl hybrids and acyclic analogs;Future Medicinal Chemistry;2024-09-12

5. Electrochemical and computational evaluation of hydrazide derivative for mild steel corrosion inhibition and anticancer study;Scientific Reports;2024-09-10